Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay-Reference-Cited by-同舟云学术

Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay

Published:2011-06-13 Issue:6 Volume:6 Page:e20947
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Miura Kazutoyo,Perera Suwani,Brockley Sarah,Zhou Hong,Aebig Joan A.,Moretz Samuel E.,Miller Louis H.,Doumbo Ogobara K.,Sagara Issaka,Dicko Alassane,Ellis Ruth D.,Long Carole A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Gamma-globulin and acquired immunity to human malaria.;S Cohen;Nature,1961

2. Malaria: a research agenda for the eradication era.;W Kilama;Lancet,2009

3. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species.;T Triglia;Mol Microbiol,2000

4. Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells.;TS Fraser;Mol Biochem Parasitol,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial;The Lancet Infectious Diseases;2024-06

2. First Phase 1b, single-center, age de-escalation trial of theP. falciparumblood-stage malaria vaccine candidate RH5.1/Matrix-M^™: a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants;2024-03-26

3. Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults;Med;2023-10

4. Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults;2023-04-20

5. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies;Cell Reports Medicine;2021-06